Nephrology

People with chronic kidney disease, even those who have undergone a kidney transplant, can benefit from regular physical exercise.

A hormone can predict which kidney patients will develop heart problems, require dialysis, or die prematurely.

Serum uric acid control in gout was poor among patients without chronic kidney disease (CKD) and even worse among those with CKD.

George Bakris, MD, discusses combination therapies for treating hypertension, chronic kidney disease, and diabetes.

The CUBN gene variant was associated with albuminuria in more than 70,000 individuals, both with and without diabetes.

Low-levels of the anti-aging hormone Klotho may presage the presence of kidney disease and its deadly cardiovascular complications.

Measuring cystatin C levels is more accurate than creatinine testing in predicting serious complications of kidney disease.

Overlapping clinical definitions of the causes and characteristics of intradialytic hypertension make it a frustrating condition to diagnose and treat

AASK trial data show mutation in MYH9 gene significantly increases risk of ESRD in African Americans with kidney disease related to hypertension.

Prominent cardiologist has some blunt advice for clinicians who are trying to apply JNC 7 guidelines in patients with CKD.

CKD stage is a predictor of incident AF and mortality risk in elderly patients. Patients with CKD also frequently exhibit major EKG abnormalities.

SHARP trial shows that combination statin therapy in patients with CKD reduces risk of heart attack and stroke without raising cancer risk.

By targeting a novel inflammatory pathway, bardoxolone methyl can reduce the stage of chronic kidney disease and improve estimated glomerular filtration rate.

Researchers continue to study the cardiovascular benefits associated with the DASH diet. Patients with CKD should adjust potassium intake.

Patients with chronic kidney disease treated by a nephrologist earlier in the care process face decreased risk of end-stage renal disease and death.

Study showing racial differences in rate of kidney function decline may point to new opportunities for kidney disease prevention.

Evidence-based strategies can alleviate gaps in providers' knowledge of chronic kidney disease and diabetes in underserved patient populations.

Type 2 diabetics with silent cerebral infarction are more than twice as likely to develop or die from end-stage kidney disease.

Research shows that early-stage CKD is related to atherosclerosis; therefore, management of CKD might lower the incidence of coronary spastic angina

Dr. Rasheed Balogun discusses the risk factors and rising worldwide incidence rates of chronic kidney disease.